Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 41 - 50 of 100+ results
Oncology
39 years of experience
Medical Oncology

Prof Siow Ming Lee is Professor of Medical Oncology and Consultant Medical Oncologist at University College London Hospital (UCLH). He is an internationally recognised authority on lung cancer treatment and research.

He has led several National Cancer Research Institute (NCRI) lung cancer trials over the past three decades in UK, which have changed clinical practice and improved treatment outcomes for lung cancer patients.

His research team established the use of gemcitabine/carboplatin chemotherapy to treat lung cancer and this treatment remains the standard chemotherapy combination to treat squamous lung cancer. His innovative trials with thalidomide as a cancer weapon and the smart drug erlotinib to treat poor performance lung cancer patients received worldwide publicity including being featured on BBC Ten O’Clock News at launch. His ET trial was the first prospective biomarker chemotherapy trial with ERCC1 to select lung cancer patients for doublet chemotherapy and demonstrated that platinum combination is superior to non-platinum chemotherapy. His latest trials examine the role of atezolizumab immunotherapy to treat poor performance non-small cell lung cancer patients (IPSOS) and hydroxychloroquine to treat small cell lung cancer (Study 15). His team was also part of the international FLAURA and KEYNOTE-189 Investigators that established osimertinib and chemotherapy-pembrolizumab combination as standard first-line therapy to treat EGFR mutant and wild-type lung cancer respectively. His trials have been recognised at major international conferences with many invited Presidential, Plenary and Oral Presentations at World Lung Cancer Conference, ASCO and ESMO and resulted in several 1st or senior author publications in high impact journals. His practice-changing trials and 4* high impact research publications were used for the REF 2014 exercise which ranked UCL top for research in UK.

Professor Lee is the Clinical Lead for the UCLH Thoracic Medical Oncology Unit and chairs the London Lung Cancer Group, which has an international research reputation. He previously was chairperson for the NCRI Lung Cancer Advanced Disease Subgroup, NCRI Brain New-agents Clinical Subgroup and committee member of CTACC, NCRI Lung, NCRI Brain and NCRI Lymphoma Groups.


Diseases, Medical Tests and Treatments


  • Targeted therapies and immunotherapy for lung cancer 
  • Non-small cell lung cancer
  • Small lung cell cancer 
  • Malignant mesothelioma
  • Thymic carcinoma 
  • HIV-related cancers
Read more
Oncology
29 years of experience
Medical Oncology

Dr Anne Armstrong is a well-respected Consultant Oncologist with HCA Healthcare and Guy's and St. Thomas' NHS Foundation Trust in London where she is the Head of Medical Oncology, along with being the lead for Systemic Treatment of Breast Cancer in South East London.

She graduated with a degree in Psychology and returned to university to study Medicine at the renowned Imperial College London. She completed her medical oncology training at numerous centres of excellence, including the Royal Marsden Hospital and Hammersmith Hospital. Following this she completed pioneering research into the molecular genetics of breast and pancreatic cancer and was awarded a PhD. In 2005 she was appointed her first Consultant post. She remains heavily involved in research, being appointed as chief investigator and of numerous breast cancer trials.


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Hormonal Therapy
  • Endocrine Therapy
  • Breast Cancer
Read more
Oncology
23 years of experience
Medical Oncology

Dr Sarker is a Senior Lecturer and Honorary Consultant in Medical Oncology at Guy’s and St Thomas’ NHS Foundation Trust, and King’s College Hospital NHS Foundation Trust. He specialises in the treatment of hepato-pancreatic-biliary malignancies: Liver Cancer, Bile Duct Cancer, Pancreatic Cancer, Neuro-endocrine Cancer, Adrenal Glands Cancer and Gall Bladder Cancer.

His main research focus is in the development of novel therapies for cancer, and together with Dr James Spicer, runs the Early Phase Clinical Trials Unit based at Guy’s Hospital. He is also actively involved in the management of hepato-pancreatic-biliary malignancies at King's College Hospital Liver Unit, and has a specific interest in the development of new therapies and molecular imaging for these tumours. Dr Sarker graduated in medicine from the University of Liverpool in 1997, and subsequently trained in internal medicine and medical oncology. In 2003 he was appointed to a Cancer Research UK Clinical Research Fellowship in the Drug Development Unit of The Royal Marsden Hospital and Institute of Cancer Research, leading to the award of a PhD. He completed his medical oncology training at The Royal Marsden in 2010.

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Molecular Imaging
  • Gastro-intestinal cancers
  • Neuro-endocrine cancers
  • Liver cancer
  • Bilary cancer
Read more
Oncology
17 years of experience
Medical Oncology

Deborah Enting is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust and an Honorary Senior Lecturer at King's College London.

She undertook her medical training at the University of Groningen in The Netherlands and trained in Medical Oncology at Guy's and St George's Hospitals. She was a research fellow at the Department of Immunobiology at King's College London and in collaboration with colleagues of the Translational Oncology Urology Research (TOUR) group at KCL she works on tumour immune surveillance and bladder cancer research.

Deborah is a Medical Oncologist specialising in the treatment of Urological Cancers and the systemic treatment (chemotherapy, immunotherapy and targeted therapies) for bladder, prostate, kidney and testicular cancers. She is a national lead on a number of clinical trials including the IRONMAN prostate cancer registry study.

 


Diseases, Medical Tests and Treatments
  • Bladder cancer
  • Prostate cancer
  • Kidney cancer
  • Testicular cancer
  • Bladder cancer
  • Prostate cancer
  • Kidney cancer
  • Testicular cancer
Read more
Oncology
19 years of experience
Clinical Oncology

Dr. Asad Qureshi is a Consultant Clinical Oncologist with many years of experience in the treatment of gastro-intestinal cancer, including oesophageal cancer, stomach cancer, colon cancer, rectal cancer, and anal cancer.

Dr. Qureshi earned his primary medical qualification at St Bartholomew's and The Royal London Hospital Medical School in 1995. Dr Qureshi then went on to undertake his specialist clinical oncology training at various renowned London hospitals Charing Cross Hospital, St Barts Hospital, Guy’s and St Thomas, and the The Royal Marsden. During this time, Dr Qureshi also completed a research degree in imagining sciences at King's College London evaluating novel radiotherapy techniques in the treatment of lung cancer. Upon completion of his training, Dr Qureshi was appointed Consultant at Guy’s and St Thomas Hospital in 2014, where he had a key role in the opening of the new Cancer Centre and has held senior management positions.

Dr Qureshi is also an active member of the scientific research community and has a keen interest in stereotactic and image-guided radiotherapy, for which he has written a number of peer-reviewed research articles. He is currently the principal investigator for various cancer clinical trials and is also an active member of the medical education community, being a clinical supervisor for clinical oncology junior doctors .

Read more
Oncology
28 years of experience
Clinical Oncology

Dr Teresa Guerrero Urbano is a Consultant Clinical Oncologist and clinical lead for Radiotherapy at Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London. She is honorary Senior Lecturer at the University of Surrey. Her areas of expertise include: Head & Neck Cancer, Non melanomatous skin cancer and Prostate cancer. Dr Guerrero Urbano has previously held senior Consultant Clinical Oncologist and Honorary Senior Lecturer positions at Royal Surrey County NHS Trust, Basingstoke and North Hampshire NHS Foundation Trust, University of Surrey. She was a Senior Research Fellow at University College London and a Clinical Cancer Research Fellow at the Institute of Cancer Research and Royal Marsden Hospital.

Dr Guerrero Urbano completed her oncology training at the Royal Marsden, Royal Surrey County and Guy’s and St Thomas’ Hospitals. She completed her PhD at the University of London in 2008. Dr Guerrero Urbano is joint Module Leader for the Respiratory, Head and Neck module, MSc in Oncology, Institute of Cancer Research. She offers weekly Oncology Seminars at St Luke’s Cancer Centre aimed at doctors, nurses, radiographers and physicists and monthly lectures at the post-graduate Medical School at the University of Surrey. She is a PhD and MD examiner. Her formal research evaluated technical and biological aspects of intensity-modulated radiotherapy at the Institute of Cancer Research/Royal Marsden Hospital. Dr Guerrero Urbano is particularly interested in the use of novel radiation techniques to minimize long-term side effects and the use of chemotherapy and targeted therapy to improve outcomes. Dr Guerrero Urbano has published her research widely and spoken at conferences worldwide.


Diseases, Medical Tests and Treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
Read more
Oncology
19 years of experience
Medical Oncology

I am a Clinical Reader and Consultant Medical Oncologist at King’s College London and Guy’s and St Thomas’ NHS Foundation Trust. I graduated from University of Oxford in pre-clinical medicine in 1998 and from Imperial College London in Clinical Medicine in 2001. After seven years of training in medicine and oncology I took three years out of my clinical training to carry out a PhD in cancer immunotherapy from King’s College London. My PhD studies were focused on genetically modifying cells for cancer immune therapy with a technique called CAR T Cell therapy. After being awarded my PhD in 2011 I returned to complete my clinical training in medical oncology. I also continued my laboratory research with a Clinical Lecturership from the National Institute for Health Research (NIHR). In 2013 I was awarded a Medical Research Council Clinician Scientist Fellowship to pursue a career at the interface between clinical practice in medical oncology and novel immune therapy research and development. I have published over twenty five peer reviewed papers. 

My research group at King's College London studies approachs to optimise personalised cell-based immune therapies for solid tumour oncology. Through vital collaborations with colleagues at King's and across the UK we are also studying the impact of immune therapies, called checkpoint inhibitor therapies, on human immune responses to help us better understand our remarkable immune systems and develop better ways of predicting, preventing and treating the immune related side effects of these crucial new drugs. 

In my clinical practice I am a medical oncologist with a practice in malignant melanoma and Merkel Cell Carcinoma. I am a principal investigator in the Guy's Cancer Early Phase drug development team where I lead trials of new therapies or combinations in cancer patients. My particular focus is on cancer immune therapies, especially cellular therapies.   I lead for skin cancer research at Guy’s and St Thomas’ NHS Foundation Trust, am our programme director for cell therapies and chair our biological safety committee. 

I belive that quality cancer care is enhanced by bringing together skills in science and clinical practice. To do this well you need to be able to bring new treatments to patients and explain them well. 

I have a young family who take up most of my spare time. And a garden I am more roud of than perhapse I should be! 


.


Diseases, Medical Tests and Treatments
  • Oncolytic viral therapy
  • T-VEC 
  • Malignant melanoma
  • Merkel cell carcinoma
Read more
Oncology
30 years of experience
Medical Oncology

 

Dr Mark Harries is a Consultant Medical Oncologist at Guy's & St Thomas' Hospitals NHS Foundation Trust and honorary senior lecturer at Kings College London School of Medicine - he also sees patients privately. He specialises in the treatment of breast cancer and melanoma.

Dr Harries graduated from Cambridge University and underwent clinical training at the Royal London Hospital. He then trained in medical oncology at the Royal Marsden Hospital and completed a PhD and post-doctoral work in the Department of Immunology at University College, London. His research interests include immunotherapy for melanoma and breast cancer as well as clinical trials of new biological agents for these diseases.

He has published many papers and presents on a regular basis at national and international conferences. He is the Oncology Editor for the International Journal of Clinical Practice. Dr Harries is also an honorary senior lecturer at King's College London School of Medicine. 

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Immunotherapy
  • Biological therapy
  • Hormonal therapy
  • Breast Cancer
  • Melanoma
Read more
Oncology
Recommended by 1 specialist
22 years of experience
Medical Oncology

Dr Kristeleit completed his undergraduate studies at the Universities of Bonn (Germany), Lausanne (Switzerland) and Barts and The London School of Medicine. He has a first class medical degree from Bonn University and performed his post graduate and specialist training in London teaching hospitals. He spent four years as an AVON Clinical Research Fellow at the Breakthrough Breast Cancer Research Centre investigating novel targets in familial breast cancer. He was appointed as a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust in 2009.

He has a special interest in breast cancer and Acute Oncology. He provides the medical oncology service for breast cancer at Queen Elizabeth and Queen Mary's hospitals and is currently the lead clinician for Acute Oncology in the South East London Accountable Cancer Network. Dr Kristeleit has a keen research interest in the role of novel therapies for breast cancer. He is an investigator on numerous clinical trials for breast cancer and chairs the oncology research committee at Guy's and St Thomas'.

He gives regular lectures for the University of London and has been invited to speak at national conferences and international meetings. He specializes in the treatment of early and advanced breast cancer.


Diseases, Medical Tests and Treatments

Read more
Dr Stephen Karp

Dr Stephen Karp

1.26 miles

Dr Stephen Karp

1.26 miles
Oncology
41 years of experience
Clinical Oncology

Dr Stephen Karp is a Consultant Clinical Oncologist at North Middlesex Hospital. His preclinical studies were at King’s College London where he also obtained an intercalated BSc in Pharmacology (1st Class Honours). He graduated in Medicine from Westminster Hospital Medical School in 1979 with a distinction in Surgery. His postgraduate training included cardiology at Hammersmith Hospital and neurology at the National Hospital Queen Square as well as general medicine at Whittington Hospital. He was a gastroenterology registrar at Northwick Park Hospital and trained in clinical oncology at the Middlesex Hospital and Mount Vernon Hospital.

Although Dr Karp was trained and initially practised in almost all areas of oncology, he is now specialized in treating cancers of the breast, GI tract (colorectal, oesophagogastric, pancreatic) and urological cancer (prostate and bladder cancer) with chemotherapy, hormone therapy, biological therapy and radiotherapy, including Cyberknife and SABR.


Diseases, Medical Tests and Treatments

  • Breast, gastrointestinal and prostate cancer (chemotherapy and radiotherapy)
  • IMRT IGRT
  • SABR
  • Cyberknife
  • Chemotherapy
  • Hormone therapy
  • Immunotherapy
  • Biological therapy
  • Breast, gastrointestinal and prostate cancer (chemotherapy and radiotherapy)
Read more